Literature DB >> 31655931

Molecular characterization of Mycoplasma pneumoniae infections in Moscow from 2015 to 2018.

Elena N Voronina1,2, Maria A Gordukova3, Irina E Turina4, Olga V Mishukova5, Maya A Dymova5, Elena V Galeeva3, Anatoliy A Korsunskiy3,4, Maxim L Filipenko5,6.   

Abstract

The aim of this study was to assess which Mycoplasma pneumoniae genotypes were present in Moscow during the years 2015-2018 and whether the proportion between detected genotypes changed over time. We were also interested in the presence of macrolide resistance (MR)Mycoplasma pneumoniae. We performed multilocus variable-number tandem-repeat (VNTR) analysis (MLVA), SNP typing, and mutation typing in the 23S rRNA gene from 117 M. pneumoniae clinical isolates. Our analysis suggests two major MLVA types: 4572 and 3562. In 2017-2018, MLVA type 4572 gradually became predominant. In general, the SNP type range is the same as described earlier for European countries. The analysis of MR mutations showed that 7% of the isolates had an A2063G mutation in the 23S rRNA gene with no isolates carrying an A2064G mutation. In 2017-2018, MLVA type 4572 (SNP type 1) begins to spread in Moscow, which was widespread globally, especially in Asian countries. SNP typing of our sample showed higher discriminatory power than MLVA typing.

Entities:  

Keywords:  MLVA; Macrolide resistance; Mycoplasma pneumoniae; SNP

Year:  2019        PMID: 31655931     DOI: 10.1007/s10096-019-03717-6

Source DB:  PubMed          Journal:  Eur J Clin Microbiol Infect Dis        ISSN: 0934-9723            Impact factor:   3.267


  20 in total

1.  Genotyping analysis of Mycoplasma pneumoniae clinical strains in Japan between 1995 and 2005: type shift phenomenon of M. pneumoniae clinical strains.

Authors:  Tsuyoshi Kenri; Norio Okazaki; Tsutomu Yamazaki; Mitsuo Narita; Kinich Izumikawa; Mayumi Matsuoka; Satowa Suzuki; Atsuko Horino; Tsuguo Sasaki
Journal:  J Med Microbiol       Date:  2008-04       Impact factor: 2.472

2.  Molecular Characterization of Mycoplasma pneumoniae Infections in Two Rural Populations of Thailand from 2009 to 2012.

Authors:  Toni Whistler; Pongpun Sawatwong; Maureen H Diaz; Alvaro J Benitez; Bernard J Wolff; Patranuch Sapchookul; Somsak Thamthitiwat; Jonas M Winchell
Journal:  J Clin Microbiol       Date:  2017-05-10       Impact factor: 5.948

3.  Multilocus variable-number tandem-repeat analysis of Mycoplasma pneumoniae clinical isolates from 1962 to the present: a retrospective study.

Authors:  Alvaro J Benitez; Maureen H Diaz; Bernard J Wolff; Guillermo Pimentel; M Kariuki Njenga; Alejandra Estevez; Jonas M Winchell
Journal:  J Clin Microbiol       Date:  2012-09-05       Impact factor: 5.948

4.  The increased incidence of Mycoplasma pneumoniae in France in 2011 was polyclonal, mainly involving M. pneumoniae type 1 strains.

Authors:  S Pereyre; A Touati; J Petitjean-Lecherbonnier; A Charron; A Vabret; C Bébéar
Journal:  Clin Microbiol Infect       Date:  2012-12-22       Impact factor: 8.067

5.  Illustration of a common framework for relating multiple typing methods by application to macrolide-resistant Streptococcus pyogenes.

Authors:  J A Carriço; C Silva-Costa; J Melo-Cristino; F R Pinto; H de Lencastre; J S Almeida; M Ramirez
Journal:  J Clin Microbiol       Date:  2006-07       Impact factor: 5.948

6.  Development of a Multilocus Sequence Typing Scheme for Molecular Typing of Mycoplasma pneumoniae.

Authors:  Rebecca J Brown; Matthew T G Holden; O Brad Spiller; Victoria J Chalker
Journal:  J Clin Microbiol       Date:  2015-07-22       Impact factor: 5.948

7.  Emergence of Macrolide-Resistant Mycoplasma pneumoniae in Hong Kong Is Linked to Increasing Macrolide Resistance in Multilocus Variable-Number Tandem-Repeat Analysis Type 4-5-7-2.

Authors:  Pak-Leung Ho; Pierra Y Law; Betsy W K Chan; Chun-Wai Wong; Kelvin K W To; Susan S Chiu; Vincent C C Cheng; Wing-Cheong Yam
Journal:  J Clin Microbiol       Date:  2015-09-02       Impact factor: 5.948

8.  Comparison of the molecular characteristics of Mycoplasma pneumoniae from children across different regions of China.

Authors:  Guanhua Xue; Ming Li; Na Wang; Jing Zhao; Bei Wang; Zhimin Ren; Chao Yan; Chengqing Wu; Yang Liu; He Sun; Min Xu; Hongmei Sun
Journal:  PLoS One       Date:  2018-08-23       Impact factor: 3.240

9.  Multiple-locus variable-number tandem-repeat analysis of mycoplasma pneumoniae clinical specimens and proposal for amendment of MLVA nomenclature.

Authors:  Hongmei Sun; Guanhua Xue; Chao Yan; Shaoli Li; Ling Cao; Yi Yuan; Hanqing Zhao; Yanling Feng; Liqiong Wang; Zhaoyang Fan
Journal:  PLoS One       Date:  2013-05-30       Impact factor: 3.240

10.  Specific multilocus variable-number tandem-repeat analysis genotypes of Mycoplasma pneumoniae are associated with diseases severity and macrolide susceptibility.

Authors:  Jiuxin Qu; Xiaomin Yu; Yingmei Liu; Yudong Yin; Li Gu; Bin Cao; Chen Wang
Journal:  PLoS One       Date:  2013-12-18       Impact factor: 3.240

View more
  4 in total

1.  Analysis of mycoplasma pneumoniae infection among children with respiratory tract infections in hospital in Chengdu from 2014 to 2020.

Authors:  Lei Zhang; Meimei Lai; Tao Ai; Huiling Liao; Yijie Huang; Ying Zhang; Yanru Liu; Li Wang; Jie Hu
Journal:  Transl Pediatr       Date:  2021-04

2.  Increased Macrolide Resistance Rate of M3562 Mycoplasma pneumoniae Correlated With Macrolide Usage and Genotype Shifting.

Authors:  Yacui Wang; Baoping Xu; Xirong Wu; Qingqin Yin; Yi Wang; Jieqiong Li; Weiwei Jiao; Shuting Quan; Lin Sun; Yonghong Wang; Adong Shen
Journal:  Front Cell Infect Microbiol       Date:  2021-05-12       Impact factor: 5.293

3.  Antimicrobial Susceptibility Profiles and Genetic Characteristics of Mycoplasma pneumoniae in Shanghai, China, from 2017 to 2019.

Authors:  Na Wang; Hong Zhang; Yihua Yin; Xiaogang Xu; Li Xiao; Yang Liu
Journal:  Infect Drug Resist       Date:  2022-08-11       Impact factor: 4.177

4.  Molecular Characterization of Mycoplasma pneumoniae Isolates in the United States from 2012 to 2018.

Authors:  L Xiao; A E Ratliff; D M Crabb; E Mixon; X Qin; R Selvarangan; Y-W Tang; X Zheng; J Dien Bard; T Hong; M Prichard; E Brooks; S Dallas; L B Duffy; K B Fowler; T P Atkinson; K B Waites
Journal:  J Clin Microbiol       Date:  2020-09-22       Impact factor: 5.948

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.